Atenção:
O eduCAPES é um repositório de objetos educacionais, não sendo responsável por materiais de terceiros submetidos na plataforma. O usuário assume ampla e total responsabilidade quanto à originalidade, à titularidade e ao conteúdo, citações de obras consultadas, referências e outros elementos que fazem parte do material que deseja submeter. Recomendamos que se reporte diretamente ao(s) autor(es), indicando qual parte do material foi considerada imprópria (cite página e parágrafo) e justificando sua denúncia.
Caso seja o autor original de algum material publicado indevidamente ou sem autorização, será necessário que se identifique informando nome completo, CPF e data de nascimento. Caso possua uma decisão judicial para retirada do material, solicitamos que informe o link de acesso ao documento, bem como quaisquer dados necessários ao acesso, no campo abaixo.
Todas as denúncias são sigilosas e sua identidade será preservada. Os campos nome e e-mail são de preenchimento opcional. Porém, ao deixar de informar seu e-mail, um possível retorno será inviabilizado e/ou sua denúncia poderá ser desconsiderada no caso de necessitar de informações complementares.
Metadados | Descrição | Idioma |
---|---|---|
Autor(es): dc.creator | Moraes, Thiago Augusto Pereira de | - |
Autor(es): dc.creator | Dias, Fernanda Carolina Ribeiro | - |
Autor(es): dc.creator | Sarmento Filha, Maria José | - |
Autor(es): dc.creator | Camara, Celso de Amorim | - |
Autor(es): dc.creator | Silva, Tania Maria Sarmento | - |
Autor(es): dc.creator | Torres, Sandra Maria de | - |
Autor(es): dc.creator | Souza, Ivone Antônia | - |
Autor(es): dc.creator | Pereira, Márcia de Figueiredo | - |
Autor(es): dc.creator | Morais, Danielle Barbosa | - |
Autor(es): dc.creator | Silva Junior, Valdemiro Amaro | - |
Data de aceite: dc.date.accessioned | 2025-08-21T15:36:59Z | - |
Data de disponibilização: dc.date.available | 2025-08-21T15:36:59Z | - |
Data de envio: dc.date.issued | 2025-02-27 | - |
Data de envio: dc.date.issued | 2022 | - |
Fonte completa do material: dc.identifier | https://www.repositorio.ufop.br/handle/123456789/19805 | - |
Fonte completa do material: dc.identifier | https://www.sciencedirect.com/science/article/pii/S0344033822005167 | - |
Fonte completa do material: dc.identifier | https://doi.org/10.1016/j.prp.2022.154272 | - |
Fonte: dc.identifier.uri | http://educapes.capes.gov.br/handle/capes/1019823 | - |
Descrição: dc.description | Quinones are naturally or synthetically occurring secondary metabolites that have various bio-dynamics, highlighting their antitumor potential. This has been explored through their selective cytotoxicity, and studies in medicinal chemistry about the relation between biological activity versus chemical structure may lead to the solution of the toxicity problems associated with quinones. In this context, the antitumor effect of a synthetic naphthoquinone, named Ethyl 2-(1,4-Dioxo-1,4-Dihydronaphthalen-2-Ylamino) Acetate, was tested using mice transplanted with Ehrlich ascitic tumor as an experimental model. The acute toxicity test was performed using 30 mice that received the aminoquinone at doses of 100, 200, 300, and 600 mg/kg. After evaluation of the clinical findings in the spontaneous activity tests, the LD50 calculation for the test substance showed low levels of toxicity at doses lower than 244.11 ± 23.29 mg/kg. Thus, three experimental groups were established, where animals transplanted with tumor cells received NaCl vehicle solution (control, n = 6), and the others were treated with 71.7 mg/kg of Methotrexate (n = 6) or 20 mg/kg of Aminoquinone (n = 6). All administrations were intraperitoneal, in a single dose. Three days after the implantation of the tumor cells the animals were weighed daily and evaluated for tumor biometry and development. The treatments occurred five days after the implantation of the tumor cells and were extended for 7 more days. At the end of the 12-day experimental period, all animals were euthanized for biochemical and histopathological analyses of the tumors and vital organs. The spontaneous activity test showed that the amount of responses associated with the nervous system tends to increase with the increase in dosage, highlighting the excitatory effect on the central nervous system in almost all dosages employed, followed by depressant activities on this system. There was a significant tumor reduction, both in animals treated with methotrexate (71.7 %) and in those treated with aminoquinone (91.6 %) in the control group. There was no significant difference in tumor volume between the animals treated with aminoquinone or methotrexate. The histopathological analysis revealed that in both treatments there were fewer mitoses in the tumor mass compared to the control group. However, there was apparent toxicity to the liver, heart, and left kidney in the treatment with methotrexate compared to aminoquinone. The significant capacity for tumor reduction presented by aminoquinone allows pointing it as a promising alternative for the development of a more efficient drug to control tumor development, being necessary for the development of new studies to deepen the knowledge about its mechanisms of action. | - |
Formato: dc.format | application/pdf | - |
Idioma: dc.language | en | - |
Direitos: dc.rights | restrito | - |
Palavras-chave: dc.subject | Cancer | - |
Palavras-chave: dc.subject | Ehrlich’s ascitic tumor | - |
Palavras-chave: dc.subject | Medicinal chemistry | - |
Palavras-chave: dc.subject | Naphthoquinones | - |
Palavras-chave: dc.subject | Toxicity | - |
Título: dc.title | Role of synthetical amynoquinone ethyl 2-(1,4-dioxo-1,4-dihydronaphthalen-2-ylamino) acetate in inhibition of Ehrlich’s tumor. | - |
Aparece nas coleções: | Repositório Institucional - UFOP |
O Portal eduCAPES é oferecido ao usuário, condicionado à aceitação dos termos, condições e avisos contidos aqui e sem modificações. A CAPES poderá modificar o conteúdo ou formato deste site ou acabar com a sua operação ou suas ferramentas a seu critério único e sem aviso prévio. Ao acessar este portal, você, usuário pessoa física ou jurídica, se declara compreender e aceitar as condições aqui estabelecidas, da seguinte forma: